iMDx Reports Results From Study Evaluating Flagship Test Kit Technology In Head-to-head Comparison With Another Commercially Available Test Kit.
Benzinga Newsdesk 1 year ago
BiotechNewsGeneral
Study indicates iMDx flagship technology's equivalence with commercially available dd-cfDNA test kitsHead-to-head comparison of iMDx's digital PCR-based test kits with NGS kits shows consistent results in 96 transplant
- Study indicates iMDx flagship technology's equivalence with commercially available dd-cfDNA test kits
- Head-to-head comparison of iMDx's digital PCR-based test kits with NGS kits shows consistent results in 96 transplant patients
- Data was presented at the European Renal Association (ERA) 2025
- Extended data to be presented at the European Society of Organ Transplantation (ESOT) Congress in London, June 29 – July 2
- Upcoming National Principal Investigator and Key Opinion Leader call planned